European Footprint

R&D and manufacturing sites in Europe

Lilly is a biopharmaceutical company with over 34,000 employees worldwide, including more than 9,000 in Europe. Founded over 140 years ago and established in Europe in 1934, our pioneering medical breakthroughs through the years include the first commercially available human insulin and the polio vaccine.

In addition to commercial activities that span the whole of Europe, we have a considerable R&D and manufacturing presence located across four countries in Europe, as well as nine beyond.

Lilly Footprint March 2022
Print our footprint here

Alcobendas, Spain

Fegersheim, France

Kinsale, Ireland

Sesto Fiorentino, Italy